Biochemical indices of vascular function, glucose metabolism and oxidative stress in horses with equine Cushing's disease
- PMID: 15147129
- DOI: 10.2746/0425164044877215
Biochemical indices of vascular function, glucose metabolism and oxidative stress in horses with equine Cushing's disease
Abstract
Reasons for performing study: The mechanisms underlying the increased risk of laminitis in horses with equine Cushing's disease (ECD) are poorly understood.
Hypothesis: That abnormalities in glucose homeostasis, similar to those which cause microvascular dysfunction in human diabetics, contribute to development of laminitis in horses with ECD.
Methods: Thirty-one aged horses were divided into 3 groups based on clinical signs and dexamethasone suppression testing (DST). Group 1 (n = 12) had clinical ECD as evidenced by hirsutism. Group 2 (n = 10) had a positive DST but no hirsutism. Group 3 (n = 9) were controls without ECD, with a negative DST and no clinical evidence of ECD. Biochemical indices of glucose metabolism, vascular function and oxidative stress were determined in single morning blood samples.
Results: Group 1 had abnormalities in glucose homeostasis, including increased levels of glucose and insulin, compared to Groups 2 and 3. Groups 1 and 2 had significantly lower plasma thiol (PSH) levels and nonsignificantly lower albumin-corrected PSH levels than Group 3, consistent with oxidative stress.
Conclusions and potential relevance: The observed abnormalities in glucose metabolism and oxidative stress could potentially contribute to development of laminitis in horses with ECD, by similar mechanisms to those that cause microvascular dysfunction in human diabetics. The absence of inter-group differences in the biochemical indices of vascular function precludes their use as preclinical diagnostic indicators of vascular dysfunction. The study also highlighted limitations in the premortem diagnosis of ECD.
Comment in
-
Cushing's syndromes, insulin resistance and endocrinopathic laminitis.Equine Vet J. 2004 Apr;36(3):194-8. doi: 10.2746/0425164044877279. Equine Vet J. 2004. PMID: 15147123 No abstract available.
Similar articles
-
Cushing's syndromes, insulin resistance and endocrinopathic laminitis.Equine Vet J. 2004 Apr;36(3):194-8. doi: 10.2746/0425164044877279. Equine Vet J. 2004. PMID: 15147123 No abstract available.
-
Increased plasma fructosamine concentrations in laminitic horses.Equine Vet J. 2012 Mar;44(2):226-9. doi: 10.1111/j.2042-3306.2011.00419.x. Epub 2011 Jun 23. Equine Vet J. 2012. PMID: 21696439
-
The role of nutritional therapy in the treatment of equine Cushing's syndrome and laminitis.Altern Med Rev. 2001 Sep;6 Suppl:S4-16. Altern Med Rev. 2001. PMID: 11591169 Review.
-
Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.Equine Vet J. 2014 Mar;46(2):249-51. doi: 10.1111/evj.12090. Epub 2013 Jul 4. Equine Vet J. 2014. PMID: 23663105
-
The role of vascular mechanisms in the development of acute equine laminitis.J Vet Intern Med. 1993 Jul-Aug;7(4):228-34. doi: 10.1111/j.1939-1676.1993.tb01012.x. J Vet Intern Med. 1993. PMID: 8246212 Review. No abstract available.
Cited by
-
Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses.J Vet Intern Med. 2021 Jan;35(1):560-570. doi: 10.1111/jvim.16017. Epub 2020 Dec 24. J Vet Intern Med. 2021. PMID: 33368633 Free PMC article.
-
Evaluation of antioxidant systems in pituitary-adrenal axis diseases.Pituitary. 2010 Jun;13(2):138-45. doi: 10.1007/s11102-009-0213-z. Pituitary. 2010. PMID: 20012698
-
Effects of Advanced Age, Pituitary Pars Intermedia Dysfunction and Insulin Dysregulation on Serum Antioxidant Markers in Horses.Antioxidants (Basel). 2020 May 21;9(5):444. doi: 10.3390/antiox9050444. Antioxidants (Basel). 2020. PMID: 32455574 Free PMC article.
-
Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes.J Endocrinol Invest. 2010 Jun;33(6):422-33. doi: 10.1007/BF03346615. J Endocrinol Invest. 2010. PMID: 20631494 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical